Vilastobart

XTX101 · Xilio Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vilastobart, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

See pricing